Efficacy of online psychoeducation and relaxation training program (OnPR) on mental health problems in COVID-19 patients: A randomized controlled trial

被引:2
|
作者
Chinvararak, Chotiman [1 ]
Kirdchok, Pantri [1 ]
Wonglertwisawakorn, Chayut [1 ]
Pumjun, Pachara [2 ]
Kerdcharoen, Nitchawan [1 ,3 ]
机构
[1] Navamindradhiraj Univ, Fac Med, Dept Psychiat, Vajira Hosp, Bangkok, Thailand
[2] Navamindradhiraj Univ, Fac Med, Dept Urban Med, Vajira Hosp, Bangkok, Thailand
[3] 681 Samsen Rd, Bangkok 10300, Thailand
关键词
Online; Psychoeducation; Relaxation training; Mental health problems; COVID-19; Randomized controlled trial; SLEEP QUALITY INDEX; SEVERITY; VALIDITY;
D O I
10.1016/j.invent.2023.100705
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Purpose: Prior studies found that the prevalence of anxiety, depression, stress and insomnia were relatively high in COVID-19 patients. This study aimed to explore the efficacy of OnPR on mental health outcomes in patients with asymptomatic or mildly symptomatic COVID-19. Patients and methods: We employed a randomized controlled trial following the CONSORT guidelines. The Thai Clinical Trials Registry identification number of this study is TCTR20220729003. We used a block of 4 randomizations generated by a computer program. The intervention group (n = 38) received the OnPR program, and the control group (n = 36) received care as usual. OnPR was an online psychological intervention comprising psychoeducation, sleep hygiene education and relaxation techniques. OnPR was provided by qualified therapists trained with a standard protocol. The primary outcomes were depression, anxiety, and stress, which were determined by the Depression Anxiety and Stress Scale-21 (DASS-21). Sleep quality was measured by the Pittsburgh Sleep Quality Index (PSQI). Outcomes were compared between groups at pre-intervention and postintervention at 1, 4, and 12 weeks using paired t -test or Wilcoxon signed-rank test. In addition, a linear mixed model was employed to demonstrate the effect changes of OnPR over time. All analyses were two-tailed, with a significance level of 0.05. Results: Of 74 Thai participants, 89.2 % were female, and 11.8 % were male. The average age was 31 years. Participants' baseline characteristics were not statistically significant between the intervention and control groups except for depression and stress scores from DASS-21. OnPR resulted in significantly better improvement in depression, anxiety, stress, and sleep quality. The mean differences between groups of DASS-21 scores in depression, anxiety and stress at 7-day follow-up were -4.69, -3.29, and -5.50 respectively. The differences continue to be significant at 4-week and 12-week follow-ups. The mean difference between groups of PSQI at 7day follow-up is -0.91. Conclusion: OnPR improved mental health outcomes, and the effect on depression, anxiety and stress lasted for at least a 12-week follow-up period. In addition, it could enhance sleep quality after the intervention.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Efficacy and safety of ivermectin in patients with mild and moderate COVID-19: A randomized controlled trial
    Malektojari, Alireza
    Ghazizadeh, Sara
    Ersi, Mohammad
    Brahimi, Elham
    Hassanipour, Soheil
    Fathalipour, Mohammad
    Hassaniazad, Mehdi
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2023, 16 (01) : 3 - 8
  • [12] Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial
    Ameri, Ali
    Asadi, Masoomeh Frouz
    Ziaei, Ava
    Vatankhah, Majid
    Safa, Omid
    Kamali, Manoochehr
    Fathalipour, Mohammad
    Mahmoodi, Masoumeh
    Hassanipour, Soheil
    INFLAMMOPHARMACOLOGY, 2023, 31 (01) : 265 - 274
  • [13] Efficacy and safety of ivermectin in patients with mild and moderate COVID-19: A randomized controlled trial
    Alireza Malektojari
    Sara Ghazizadeh
    Mohammad Hamed Ersi
    Elham Brahimi
    Soheil Hassanipour
    Mohammad Fathalipour
    Mehdi Hassaniazad
    Asian Pacific Journal of Tropical Medicine, 2023, 16 (01) : 3 - 8
  • [14] Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial
    Beltran Gonzalez, Jose Lenin
    Gonzalez Gamez, Mario
    Mendoza Enciso, Emanuel Antonio
    Esparza Maldonado, Ramiro Josue
    Hernandez Palacios, Daniel
    Duenas Campos, Samuel
    Ovalle Robles, Itzel
    Macias Guzman, Mariana Jocelyn
    Garcia Diaz, Andrea Lucia
    Gutierrez Pena, Cesar Mauricio
    Martinez Medina, Lucila
    Monroy Colin, Victor Antonio
    Arreola Guerra, Jose Manuel
    INFECTIOUS DISEASE REPORTS, 2022, 14 (02) : 160 - 168
  • [15] Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial
    Ali Ameri
    Masoomeh Frouz Asadi
    Ava Ziaei
    Majid Vatankhah
    Omid Safa
    Manoochehr Kamali
    Mohammad Fathalipour
    Masoumeh Mahmoodi
    Soheil Hassanipour
    Inflammopharmacology, 2023, 31 : 265 - 274
  • [16] A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19
    Kharazmi, Amir Behnam
    Moradi, Omid
    Haghighi, Mehrdad
    Kouchek, Mehran
    Manafi-Rasi, Alireza
    Raoufi, Masoomeh
    Shoaei, Simin Dokht
    Hadavand, Fahimeh
    Nabavi, Mahmood
    Miri, Mir Mohammad
    Salarian, Sara
    Shojaei, Seyedpouzhia
    Khalili, Shayesteh
    Sistanizad, Mohammad
    Sadeghi, Setayesh
    Karagah, Amirhossein
    Asgari, Saemeh
    Jaffaraghaei, Morteza
    Araghi, Shahram
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (02) : 201 - 208
  • [17] Mental health and health behaviors among college student mentors in a randomized controlled trial interrupted by COVID-19
    Miller, Reagan L.
    Moran, Megan
    Lucas-Thompson, Rachel G.
    Sanchez, Natalia
    Seiter, Natasha
    Rayburn, Stephanie
    Verros, Megan
    Haddock, Shelley A.
    Zimmerman, Toni S.
    Johnson, Sarah A.
    Shomaker, Lauren B.
    JOURNAL OF AMERICAN COLLEGE HEALTH, 2024, 72 (06) : 1646 - 1650
  • [18] Effects of aerobic training on cardiopulmonary fitness in patients with long COVID-19: a randomized controlled trial
    Bai, Bingqing
    Xu, Mingyu
    Zhou, Haofeng
    Liao, Yingxue
    Liu, Fengyao
    Liu, Yuting
    Yuan, Youyong
    Geng, Qingshan
    Ma, Huan
    TRIALS, 2024, 25 (01)
  • [19] Exercise rehabilitation in post COVID-19 patients: a randomized controlled trial of different training modalities
    Sick, Johanna
    Steinbacher, Verena
    Kotnik, Daniel
    Koenig, Florian
    Recking, Tim
    Bengsch, Dominik
    Koenig, Daniel
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2025, 61 (01) : 130 - 140
  • [20] Efficacy of Quinine Sulfate in Patients with Mild-To-Moderate COVID-19: A Randomized Controlled Trial
    Latarissa, Irma Rahayu
    Barliana, Melisa Intan
    Meiliana, Anna
    Sormin, Ida Paulina
    Sugiono, Erizal
    Kartasasmita, Cissy Bana
    Irmansyah
    Lestari, Keri
    INDONESIAN BIOMEDICAL JOURNAL, 2023, 15 (06): : 366 - 374